New injection aims to melt belly fat without surgery

NCT ID NCT07608770

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 2b trial tests an injection called CBL-514 to see if it can safely reduce abdominal fat. About 250 adults with moderate to high belly fat will receive either the drug or a placebo. The main goal is to measure fat reduction using MRI scans over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CBL-514 injection

What this could lead to

If successful, this could offer a non-surgical option to reduce belly fat in people with moderate to high abdominal fat.

What could go wrong

This is an early phase 2b trial, so results are not yet proven. The treatment may not work better than placebo, and side effects are still being studied.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBCUTANEOUS FAT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site 1

    RECRUITING

    South Yarra, Victoria, 3141, Australia